AI aims to help babies born addicted to opioids
NCT ID NCT06303986
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study gathers health data from 100 newborns, some with neonatal abstinence syndrome (NAS) and some healthy, to train an artificial intelligence system. The goal is to create a tool that automatically scores NAS symptoms using continuous monitoring, reducing human bias and improving care. The research does not test any drug or treatment, only collects information for future AI development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a more objective, automated way to monitor and treat newborns with NAS, potentially reducing hospital stays.
What could go wrong
This is an early data-collection study, not a treatment trial. The AI algorithm may not perform as expected, and results may not apply to all hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL ABSTINENCE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of New Mexico
Albuquerque, New Mexico, 87106, United States